Crazy huh. My guess the number of share shorted probably exceeds the shares outstanding. DTC and SEC need to be notified.
Jul 30 40.75%
Jul 29 31.14%
Jul 28 31.50%
Jul 27 37.76%
Jul 24 50.32%
Jul 23 52.83%
Another word of advise, key support levels rarely get breeched, usually happens when fundamentals have changed for the worse. It was masterful how some unnamed hedge funds try to create uncertainty around a CC; especially for Bio's by creating huge selloffs so wall street thinks something must be wrong...sell first ask questions later. Now Wall Street is asking questions, and realizing this is a great buy, the CC was stellar.
support level that held yesterday. For the clowns that predicted gloom, claiming support levels were breached...a word of advise from someone that did this for a living and learned technical analysis from John Murphy, it's the close price that counts. I didn't make any moves yesterday. The early going appears we will maintain support and gap integrity. IMHO.
It's another mega opportunity. Like COPD, it will whack the current present value projections. They must go up. I plan to buy more.
Sentiment: Strong Buy
More short interest data from the FDA news time period. You'd thought they would cover, but shorted more--LOL. Almost 65% on 7/09.
38.84% 3.04 2.73 3.02 460,561 1,185,919
Jul 14 37.37% 2.69 2.62 2.64 33,090 88,552
Jul 13 55.54% 2.67 2.57 2.64 50,345 90,651
Jul 10 51.28% 2.64 2.53 2.64 38,026 74,152
Jul 09 64.67% 2.60 2.51 2.56 33,321 51,522
Jul 08 52.64% 2.63 2.44 2.61 107,400 204,010
There is definitely someone trying to keep it down. Short Interest spiked at almost 63% of the share s traded on 7/17.
Jul 28 31.50% 3.03 2.88 2.90 174,501 553,927
Jul 27 37.76% 3.12 2.98 3.02 201,263 532,966
Jul 24 50.32% 3.25 3.07 3.14 105,481 209,606
Jul 23 52.83% 3.32 3.11 3.17 83,059 157,226
Jul 22 34.97% 3.38 3.06 3.27 101,795 291,126
Jul 21 36.98% 3.59 3.30 3.36 133,322 360,560
Jul 20 59.54% 3.65 3.36 3.54 519,776 872,941
Jul 17 62.92% 3.59 3.05 3.36 517,329 822,255
I am watching it. I do think the patent issues are greater than the Seeking Alpha article portrayed. Already the Co-owner of the patent has back away and didn't signed the agreement that would have sealed the patents for AVXL. The other issue is the new compounds developed by AVXL, they could be construed to be derivatives of the original patent. The Co-owner could find another Pharma or Biotech that will run with it, after all he is an owner. Also I anticipate further dilution. When these get cleared up then buy.
George love your enthusiasm, I agree the potential is huge. I am thinking how great for our mothers, daughters, sisters, to have a potential cure for ovarian cancer. I am thinking they continue to more cohorts for other cancers, while they go forward with PIII for Ovarian. God bless you too George.
My opinion...Buy all you can NOW. It will help with future tuition bills. I am a retired technical trader, learned from the best.
Press release from Street Insider had $135, Must have it wrong. $132 is a good start IMHO.
them saying they believe the Co has met all their key milestones. It's based on a 10 year model discounted to present. Not sure what they mean on all the milestones...does that include solid tumor data? These guys are ultra conservative.
Short term, low to mid $50's. Based on the last weekly trend turn and run up from the low projecting out it would be $140. Keep in mind, it depends on market forces on how long it gets there. Also this is a technical projection, doesn't factor in the impact of fundamentals like trial news. I can't predict the value the market will place on new info that changes the value equation until we know it. The market clearly mispriced this Co.and woke up to the COPD possibilities thanks to Roth Capital...still mispriced.
That was the old range. The new range starts with where the gap up started. You should be buying here. My dear friend.
Your biggest profits come staying long on small bios with the number of catalysts this one has coming. That's how I got rich. If I day or swing traded, I would ha 've missed out on numerous buyouts, and unpredictable changes in trend. And I am a professional at technical analysis.
Sentiment: Strong Buy
Should note that the higher this goes, it could trigger a BO offer from an interested party. They wouldn't want it to get too high too fast if they want it around $100-$125, which is cheap.